Moreau P.,University of Nantes |
Attal M.,University Hospital Purpan |
Harousseau J.L.,Cancer Center Rene Gauducheau
Bone Marrow Transplantation | Year: 2011
The current standard conditioning regimen before auto-SCT in patients with multiple myeloma is melphalan 200 mg/m 2. Several attempts have recently been made to improve this aspect of the high-dose therapy procedure. The scope of this review article is to summarize current knowledge on conditioning regimens in this setting. © 2011 Macmillan Publishers Limited All rights reserved.